Arrow Mark Colorado Holdings LLC Veracyte, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$5.48 Billion
Q1 2025

A detailed history of Arrow Mark Colorado Holdings LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 3,226,673 shares of VCYT stock, worth $85.5 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

3,226,673

Previous 3,080,027 4.76%

Holding current value

$85.5 Million

Previous $122 Million 21.56%

% of portfolio

1.75%

Previous 1.83%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$29.65 - $46.14 $4.35 Million - $6.77 Million	146,646 Added 4.76%	3,226,673 $95.7 Million
Q4 2024 Feb 14, 2025	BUY	$31.92 - $44.4 $3.12 Million - $4.34 Million	97,824 Added 3.28%	3,080,027 $122 Million
Q3 2024 Nov 14, 2024	SELL	$21.0 - $35.25 $327,180 - $549,195	-15,580 Reduced 0.52%	2,982,203 $101 Million
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $6.69 Million - $8.35 Million	354,538 Added 13.41%	2,997,783 $65 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $2.65 Million - $3.67 Million	126,105 Added 5.01%	2,643,245 $58.6 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $2.49 Million - $3.62 Million	126,161 Added 5.28%	2,517,140 $69.2 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $3.74 Million - $4.82 Million	178,414 Added 8.06%	2,390,979 $60.9 Million
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $11.9 Million - $16.1 Million	-577,105 Reduced 20.69%	2,212,565 $49.3 Million
Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $914,772 - $1.79 Million	-59,750 Reduced 2.1%	2,789,670 $66.2 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $14.1 Million - $23.8 Million	-852,556 Reduced 23.03%	2,849,420 $47.3 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $9.46 Million - $18.1 Million	612,533 Added 19.83%	3,701,976 $73.7 Million
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $12.3 Million - $23.9 Million	562,021 Added 22.24%	3,089,443 $85.2 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $655,827 - $977,471	18,172 Added 0.72%	2,527,422 $104 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $831,299 - $1.24 Million	-23,338 Reduced 0.92%	2,509,250 $117 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $33.2 Million - $57.1 Million	1,008,289 Added 66.15%	2,532,588 $101 Million
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $32.7 Million - $59.8 Million	735,121 Added 93.15%	1,524,299 $81.9 Million
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $2.05 Million - $3.9 Million	-63,022 Reduced 7.4%	789,178 $38.6 Million
Q3 2020 Nov 16, 2020	SELL	$26.73 - $35.67 $7.29 Million - $9.72 Million	-272,583 Reduced 24.23%	852,200 $27.7 Million
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $428 - $618	-22 Reduced -0.0%	1,124,783 $29.1 Million
Q1 2020 May 15, 2020	BUY	$16.13 - $30.17 $18.1 Million - $33.9 Million	1,124,805 New	1,124,805 $27.3 Million

Others Institutions Holding VCYT

# of Institutions

306

Shares Held

79.1M

Call Options Held

15.5K

Put Options Held

16.7K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.9B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account

Arrow Mark Colorado Holdings LLC Veracyte, Inc. Transaction History